Medical, Surgical, and Genetic Treatment of Huntington Disease
- PMID: 32279715
- DOI: 10.1016/j.ncl.2020.01.010
Medical, Surgical, and Genetic Treatment of Huntington Disease
Abstract
Huntington disease, a neurodegenerative disease characterized by progressive motor, behavioral, and cognitive decline, is caused by a CAG trinucleotide repeat expansion in the huntingtin gene on chromosome 4. Current treatments target symptom management because there are no disease-modifying therapies at this time. Investigation of RNA-based and DNA-based treatment strategies are emerging and hold promise of possible future disease-modifying therapy.
Keywords: Antipsychotic drugs; Antisense oligonucleotides; Deep brain stimulation; Huntington disease; Vesicular monoamine transporter type 2 inhibitors.
Copyright © 2020 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
